Sumanta K. Pal, MD, on RCC and Tumor Profiling

2017 Genitourinary Cancers Symposium
Tweet this page

Sumanta K. Pal, MD, of the City of Hope, discusses the evolution of circulating tumor DNA profile from first-line to second-line therapy in metastatic renal cell carcinoma. (Abstract 434)

Advertisement

Advertisement



Advertisement